License Agreements in the Pharmaceuticals Industry

1,224 Contracts & Agreements

Browse by Company

60 DEGREES PHARMACEUTICALS, INC. (5 contracts)
Accelerated Pharma, Inc. (2)
ACELRX PHARMACEUTICALS INC (2)
Acer Therapeutics Inc. (9)
Aclaris Therapeutics, Inc. (3)
ACURA PHARMACEUTICALS, INC (6)
Adamis Pharmaceuticals Corp (12)
ADIAL PHARMACEUTICALS, INC. (8)
Aegerion Pharmaceuticals, Inc. (6)
AEON Biopharma, Inc. (2)
Aerpio Pharmaceuticals, Inc. (5)
AGILE THERAPEUTICS INC (2)
Akers Biosciences, Inc. (1)
AKESIS PHARMACEUTICALS, INC. (1)
Akorn (2)
ALDER BIOPHARMACEUTICALS INC (2)
Alexza Pharmaceuticals Inc. (4)
ALIMERA SCIENCES INC (1)
ALSERES PHARMACEUTICALS INC (9)
Altus Pharmaceuticals Inc. (4)
Amag Pharmaceuticals (4)
Ampio Pharmaceuticals, Inc. (4)
AMYLIN PHARMACEUTICALS INC (1)
AN2 Therapeutics, Inc. (2)
Anacor Pharmaceuticals, Inc. (2)
Anebulo Pharmaceuticals, Inc. (1)
Angion Biomedica Corp. (2)
ANGIOTECH PHARMACEUTICALS INC (8)
ANI Pharma Inc (10)
Anthera Pharmaceuticals Inc (1)
Apimeds Pharmaceuticals US, Inc. (1)
APRICUS BIOSCIENCES, INC. (8)
Aquestive Therapeutics, Inc. (5)
ARADIGM CORP (1)
Aralez Pharmaceuticals Inc. (3)
ARIAD PHARMACEUTICALS INC (5)
Arog Pharmaceuticals, Inc. (3)
ARTELO BIOSCIENCES, INC. (10)
Artemis Therapeutics, Inc. (2)
ARVINAS, INC. (6)
Assertio Holdings, Inc. (1)
Assertio Therapeutics, Inc (5)
Astex Pharmaceuticals, Inc (5)
ATAI Life Sciences B.V. (3)
Atea Pharmaceuticals, Inc. (1)
AUXILIUM PHARMACEUTICALS INC (17)
AVADEL PHARMACEUTICALS PLC (3)
AVALON PHARMACEUTICALS INC (2)
AVANIR PHARMACEUTICALS, INC. (1)
AVENUE THERAPEUTICS, INC. (1)
Axsome Therapeutics, Inc. (1)
AYTU BIOSCIENCE, INC (9)
Bakhu Holdings, Corp. (5)
BARR PHARMACEUTICALS INC (2)
Baudax Bio, Inc. (6)
Bausch Health Companies Inc. (1)
BENTLEY PHARMACEUTICALS INC (1)
Big Rock Partners Acquisition Corp. (1)
BIODELIVERY SCIENCES INTERNATIONAL INC (17)
Biofrontera Inc. (6)
Biohaven Ltd. (3)
BioNumerik Pharmaceuticals, Inc. (2)
BioPharmX Corp (1)
BODY & MIND INC. (1)
Boston Therapeutics, Inc. (5)
BRADLEY PHARMACEUTICALS INC (1)
Braeburn Pharmaceuticals, Inc. (1)
CADENCE PHARMACEUTICALS INC (1)
CALLISTO PHARMACEUTICALS INC (2)
Canbiola, Inc. (1)
Cancer Prevention Pharmaceuticals, Inc. (4)
Cannabics Pharmaceuticals Inc. (3)
CANNAPOWDER, INC. (1)
Cantabio Pharmaceuticals Inc. (1)
Cara Therapeutics, Inc. (7)
CASSAVA SCIENCES INC (5)
CELGENE CORP (1)
Cerecor Inc. (11)
Charlotte's Web Holdings, Inc. (7)
CinCor Pharma, Inc. (1)
Cingulate Inc. (1)
Citius Pharmaceuticals, Inc. (11)
Clearside Biomedical, Inc. (15)
CNS Pharmaceuticals, Inc. (2)
Cocrystal Pharma, Inc. (6)
COLLEGIUM PHARMACEUTICAL, INC (1)
CoLucid Pharmaceuticals, Inc. (2)
Context Therapeutics Inc. (3)
ContraVir Pharmaceuticals, Inc. (1)
CorMedix Inc. (4)
COSMO VENTURES INC (7)
CPEX Pharmaceuticals, Inc. (1)
CUBIST PHARMACEUTICALS INC (10)
CUMBERLAND PHARMACEUTICALS INC (2)
CymaBay Therapeutics, Inc. (4)
Dermata Therapeutics, Inc. (2)
Dova Pharmaceuticals Inc. (1)
DURECT CORP (25)
DUSA PHARMACEUTICALS INC (1)
Egalet Corp (6)
Elanco Animal Health Inc (2)
ELITE PHARMACEUTICALS INC (20)
Elixir Pharmaceuticals, Inc. (4)
Eloxx Pharmaceuticals, Inc. (17)
Endo International plc (4)
Endo Pharmaceuticals Solutions Inc. (10)
EPIX Pharmaceuticals, Inc. (5)
Eton Pharmaceuticals, Inc. (3)
Evofem Biosciences, Inc. (3)
Evolus, Inc. (8)
EYEGATE PHARMACEUTICALS INC (9)
EYENOVIA, INC. (7)
EyePoint Pharmaceuticals, Inc. (4)
EYETECH PHARMACEUTICALS INC (3)
Fulcrum Therapeutics, Inc. (3)
GRAYBUG VISION, INC. (1)
GUILFORD PHARMACEUTICALS INC (4)
Harmony Biosciences Holdings, Inc. (3)
HARROW HEALTH, INC. (10)
Horizon Pharma plc (21)
Hoth Therapeutics, Inc. (7)
IDENIX PHARMACEUTICALS INC (7)
Ikena Oncology, Inc. (2)
IMAGING3 INC (2)
IMARA Inc. (5)
INNOVATE BIOPHARMACEUTICALS, INC. (6)
Innoviva, Inc. (1)
Innovive Pharmaceuticals, Inc. (3)
INSPIRE PHARMACEUTICALS INC (7)
IntelGenx Technologies Corp. (1)
Intra-Cellular Therapies, Inc. (4)
ISTA PHARMACEUTICALS INC (2)
Item 9 Labs Corp. (1)
Iterum Therapeutics plc (1)
Jaguar Health, Inc. (9)
Jazz Pharmaceuticals plc (14)
Journey Medical Corp (5)
JUNIPER PHARMACEUTICALS INC (13)
Kala Pharmaceuticals, Inc. (5)
Kannalife Inc (2)
KING PHARMACEUTICALS INC (5)
KOS PHARMACEUTICALS INC (2)
Lannett Company, Inc. (3)
Level Brands, Inc. (6)
Lexaria Bioscience Corp. (16)
Lipocine Inc. (3)
Liquidia Corp (5)
Longboard Pharmaceuticals, Inc. (3)
Lowell Farms Inc. (1)
Luckwel Pharmaceuticals Inc. (3)
Lumena Pharmaceuticals, Inc. (3)
MAP Pharmaceuticals, Inc. (4)
MARINUS PHARMACEUTICALS INC (2)
MAXIM PHARMACEUTICALS INC (2)
Medicine Man Technologies, Inc. (4)
MEMORY PHARMACEUTICALS CORP (1)
Menlo Therapeutics Inc. (5)
MiddleBrook Pharmaceuticals, Inc. (1)
MIRA PHARMACEUTICALS, INC. (3)
MJ Holdings, Inc. (2)
Molecular Insight Pharmaceuticals, Inc. (13)
MYnd Analytics, Inc. (1)
Nabriva Therapeutics plc (3)
NEKTAR THERAPEUTICS (4)
Neos Therapeutics, Inc. (2)
Neuralstem, Inc. (3)
NEW RIVER PHARMACEUTICALS INC (1)
NewBridge Global Ventures, Inc. (3)
NEXIEN BIOPHARMA, INC. (2)
NovaBay Pharmaceuticals, Inc. (2)
Novan, Inc. (15)
NOVEN PHARMACEUTICALS INC (1)
NPS PHARMACEUTICALS INC (16)
OCULAR THERAPEUTIX, INC (5)
Odonate Therapeutics, Inc. (1)
OMEROS CORP (10)
Omthera Pharmaceuticals, Inc. (2)
OncoMed Pharmaceuticals Inc (13)
Onconova Therapeutics, Inc. (3)
ONYX PHARMACEUTICALS INC (1)
OPIANT PHARMACEUTICALS, INC. (11)
OPTIMER PHARMACEUTICALS INC (2)
OptiNose, Inc. (3)
ORAMED PHARMACEUTICALS INC. (2)
Organon & Co. (1)
OSCIENT PHARMACEUTICALS CORP (8)
OSI PHARMACEUTICALS INC (6)
Osmotica Pharmaceuticals plc (1)
OTONOMY, INC. (2)
Panacea Acquisition Corp (4)
PANACOS PHARMACEUTICALS, INC. (3)
Paratek Pharmaceuticals, Inc. (19)
PaxMedica, Inc. (4)
PEAK PHARMACEUTICALS, INC. (1)
Petros Pharmaceuticals, Inc. (3)
Phathom Pharmaceuticals, Inc. (3)
Phoenix Life Sciences International Limited. (1)
Pivot Pharmaceuticals Inc. (2)
PLx Pharma Inc. (7)
PONIARD PHARMACEUTICALS, INC. (2)
PREDIX PHARMACEUTICALS HOLDINGS INC (2)
PRESTWICK PHARMACEUTICALS INC (2)
Processa Pharmaceuticals, Inc. (10)
ProPhase Labs, Inc. (2)
PROTEO INC (2)
PROVECTUS BIOPHARMACEUTICALS, INC. (1)
Provention Bio, Inc. (7)
Pulmatrix, Inc. (6)
QUARK PHARMACEUTICALS INC (14)
QUATRX PHARMACEUTICALS CO (6)
QUESTCOR PHARMACEUTICALS INC (1)
Quoin Pharmaceuticals, Ltd. (1)
Ra Pharmaceuticals, Inc. (2)
RADIENT PHARMACEUTICALS Corp (6)
Rain Therapeutics Inc. (3)
Rani Therapeutics Holdings, Inc. (4)
REATA PHARMACEUTICALS INC (22)
Recro Pharma, Inc. (8)
Reliant Pharmaceuticals, Inc. (10)
RELMADA THERAPEUTICS, INC. (5)
RespireRx Pharmaceuticals Inc. (8)
resTORbio, Inc. (10)
Revance Therapeutics, Inc. (7)
Rib-X Pharmaceuticals, Inc. (6)
ROCK CREEK PHARMACEUTICALS, INC. (1)
Roivant Sciences Ltd. (4)
SALIX PHARMACEUTICALS LTD (13)
SAVIENT PHARMACEUTICALS INC (1)
SCICLONE PHARMACEUTICALS INC (1)
Scopus BioPharma Inc. (7)
scPharmaceuticals Inc. (1)
SCYNEXIS INC (11)
SenesTech, Inc. (1)
SHAMAN PHARMACEUTICALS INC (1)
Somanta Pharmaceuticals Inc. (1)
Sonoma Pharmaceuticals, Inc. (9)
Strongbridge Biopharma plc (1)
Sucampo Pharmaceuticals, Inc. (4)
Supernus Pharmaceuticals, Inc. (8)
Synovics Pharmaceuticals (1)
Target Group Inc. (1)
Tarsus Pharmaceuticals, Inc. (5)
TAURIGA SCIENCES, INC. (4)
Telomir Pharmaceuticals, Inc. (2)
Terns Pharmaceuticals, Inc. (3)
TETRALOGIC PHARMACEUTICALS CORP (2)
TETRAPHASE PHARMACEUTICALS INC (2)
Textmunication Holdings, Inc. (1)
TFF Pharmaceuticals, Inc. (3)
The Medicines Company (1)
TherapeuticsMD, Inc. (4)
Theravance Biopharma, Inc. (3)
Theseus Pharmaceuticals, Inc. (1)
TITAN PHARMACEUTICALS INC (4)
Trevi Therapeutics, Inc. (4)
Tribute Pharmaceuticals Canada Inc. (3)
United Cannabis Corp (1)
Urigen Pharmaceuticals, Inc. (5)
Urovant Sciences Ltd. (3)
Valera Pharmaceuticals Inc (4)
Vallon Pharmaceuticals, Inc. (1)
Verrica Pharmaceuticals Inc. (1)
VIA Pharmaceuticals, Inc. (6)
Virpax Pharmaceuticals, Inc. (6)
Vitality Biopharma, Inc. (3)
VIVUS INC (7)
Wave Life Sciences Ltd. (3)
WEED, INC. (1)
Zoetis (5)
ZOGENIX, INC. (5)
Zomedica Pharmaceuticals Corp. (5)

Recent Contracts

Category

Company

Industry

Jur. Jurisdiction

Filed

FIRST AMENDMENT TO UNITED STATES LICENSE AND COLLABORATIONAGREEMENT

License Agreements

Paratek Pharmaceuticals, Inc.

Pharmaceuticals

2012

Amendment No. 2 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated March 6, 2018

License Agreements

DURECT CORP

2024

Amendment No. 1 to Exclusive License Agreement between the Company and Virginia Commonwealth University Intellectual Property Foundation dated July 2, 2015

License Agreements

DURECT CORP

2024

First Amendment to the License Agreement, dated as of October 2, 2024, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc

License Agreements

Liquidia Corp

2024

Device License Agreement, dated as of October 2, 2024, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc

License Agreements

Liquidia Corp

2024

First Amendment to the License Agreement by and between Bayer Aktiengesellschaft and Pulmovant, Inc., dated as of September 22, 2023

License Agreements

Roivant Sciences Ltd.

2024

License Agreement by and between Bayer Aktiengesellschaft and Pulmovant, Inc., dated as of July 27, 2023

License Agreements

Roivant Sciences Ltd.

2024

Rest of World License Term Sheet, dated October 8, 2024, between Oramed Pharmaceuticals Inc., Scilex Holding Company and the other parties signatories thereto

License Agreements

ORAMED PHARMACEUTICALS INC.

2024

Patent License Agreement by and between Apimeds Pharmaceuticals US, Inc. and Dr. Christopher Kim, dated October 12, 2021

License Agreements

Apimeds Pharmaceuticals US, Inc.

2024

LICENSE AGREEMENT

License Agreements

Context Therapeutics Inc.

2024

Intellectual Property Cross License Agreement, dated as of May 28, 2024, by and between Pulmatrix, Inc. and MannKind Corporation

License Agreements

Pulmatrix, Inc.

2024

First Amendment to License Agreement, by and among the Registrant and BioCryst Pharmaceuticals, Inc., dated as of May 20, 2024

License Agreements

Clearside Biomedical, Inc.

2024

Exclusive License Agreement between CNS Pharmaceuticals, Inc. and Cortice Biosciences, Inc

License Agreements

CNS Pharmaceuticals, Inc.

2024

License Agreement, by and between the Company and Pharma 1 Drug Store, L.L.C

License Agreements

Evofem Biosciences, Inc.

2024

License and Commercialization Agreement between Nippon Kayaku Co., Ltd. and AnHeart Therapeutics Inc, dated October 27, 2023

License Agreements

Panacea Acquisition Corp

2024

License Agreement between Daiichi Sankyo Company, Limited and AnHeart Therapeutics Inc., dated September 7, 2020

License Agreements

Panacea Acquisition Corp

2024

First Amendment to License Agreement between Daiichi Sankyo Company, Limited and AnHeart Therpaeutics Inc., dated August 17, 2020

License Agreements

Panacea Acquisition Corp

2024

License Agreement between Daiichi Sankyo Company, Limited and AnHeart Therapeutics Inc., dated December 7, 2018

License Agreements

Panacea Acquisition Corp

2024

First Amendment to Amended and Restated License Agreement, dated March 16, 2024, by and between Napo Pharmaceuticals, Inc. and Nano Therapeutics S.p.A

License Agreements

Jaguar Health, Inc.

2024

First Amendment to License Agreement, dated

License Agreements

Cerecor Inc.

2024

License Agreement by, dated November 25, 2019, by and between Flame Biosciences LLC and Eli Lilly and Company

License Agreements

Cerecor Inc.

2024

Amended and Restated License Agreement, dated January 27, 2012, between the Registrant and Incept LLC

License Agreements

OCULAR THERAPEUTIX, INC

2024

Amendment No. 2 to License and Commercialization Agreement, dated July 28, 2017, by and between Bioprojet Socit Civile de Recherche and Harmony Biosciences, LLC

License Agreements

Harmony Biosciences Holdings, Inc.

2024

Amendment No. 1 to License and Commercialization Agreement, dated July 31, 2022, by and between Bioprojet Socit Civile de Recherche and Harmony Biosciences, LLC

License Agreements

Harmony Biosciences Holdings, Inc.

2024

Amended and Restated Intellectual Property License Agreement with Premier Anti-Aging Co., Ltd. dated March 15, 2024

License Agreements

Lexaria Bioscience Corp.

2024

License Agreement, effective November 1, 2021, by and between The Wheelership LLC and Assisi Animal Health, as assumed by Zomedica Inc. effective July 15, 2022

License Agreements

Zomedica Pharmaceuticals Corp.

2024

Amendment No. 2 to License Agreement with an effective date of January 25, 2013 between Omeros Corporation and Daiichi Sankyo Co., Ltd

License Agreements

OMEROS CORP

2024

Amendment No. 1 to License Agreement with an effective date of January 5, 2011 between Omeros Corporation and Daiichi Sankyo Co., Ltd

License Agreements

OMEROS CORP

2024

License Agreement between Omeros Corporation and Daiichi Sankyo Co., Ltd. (successor-in-interest to Asubio Pharma Co., Ltd.) dated March 3, 2010

License Agreements

OMEROS CORP

2024

Binding Memorandum of Understanding for Amendment to Exclusive License Agreement and Transitional Manufacturing and Supply Agreement, dated as of December 26, 2023, by and between...

License Agreements

SCYNEXIS INC

2024

Exclusive License Agreement (with Equity), dated March 21, 2024, by and between the Company and University of Miami

License Agreements

PROVECTUS BIOPHARMACEUTICALS, INC.

2024

License Agreement Dated June 15, 2023 by and between Star Brands and Medicine Man Technologies, Inc

License Agreements

Medicine Man Technologies, Inc.

2024

Third Amendment to License and Supply Agreement dated February 6, 2024 between Harrow IP, LLC and Sintetica S.A

License Agreements

HARROW HEALTH, INC.

2024

License Agreement, effective as of March20, 2024, by and between cbdMD, Inc. and HSKL, Inc

License Agreements

Level Brands, Inc.

2024

License Agreement, dated as of June 28, 2023, by and between Liquidia Technologies, Inc. and Pharmosa Biopharm Inc

License Agreements

Liquidia Corp

2024

Fourth Amendment to License Agreement, by and among the Registrant, Emory University and The Georgia Tech Research Corporation, dated January 31, 2024

License Agreements

Clearside Biomedical, Inc.

2024

License Agreement, by and between the Registrant and BioCryst Pharmaceuticals, Inc., dated as of November 1, 2023

License Agreements

Clearside Biomedical, Inc.

2024

License, Supply, and Distribution Agreement (Europe), dated as of December 20, 2024, by and between Evolus Pharma B.V. and Symatese Aesthetics S.A.S

License Agreements

Evolus, Inc.

2024

Second Amendment to License and Supply Agreement, dated as of July 15, 2014, by and between Daewoong Pharmaceutical Co., Ltd. and the Registrant

License Agreements

Evolus, Inc.

2024

First Amendment to License and Supply Agreement, dated as of February 26, 2014, by and between Daewoong Pharmaceutical Co., Ltd. and the Registrant

License Agreements

Evolus, Inc.

2024

License Agreement dated January 12, 2024 by and among Lipocine, Inc., Gordon Silver Limited, and Verity Pharmaceuticals

License Agreements

Lipocine Inc.

2024